Medical Health & Life Science Research News

Research report explores the global mycoplasma testing market

Mycoplasma Testing Market by Product (Kits & Reagents, Instruments and services), by Technique (PCR, ELSA, Direct Assays, Indirect Assays, Microbial culture techniques, Enzymatic Methods, and DNA Staining), by Application (Cell Line Testing, Virus Testing, End-Of-Production Cell Testing and others), by End User (Pharmaceutical Companies, Contract research organizations, Academic Research Institutes and Cell Banks) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

- Advertising -

The Global mycoplasma testing market was worth USD 465.1 Million in 2016 and is estimated to be growing at a CAGR of 12.7%, to reach USD 845.7 Million by 2021. Mycoplasma is a type of bacteria and they do not possess a cell wall or cell membrane.

Since, most of the common antibiotics are designed to target cell wall synthesis; they do not work against Mycoplasma. They are one of the smallest bacteria and cannot be observed using a normal microscope.

- Advertising -

Browse Full Report at www.marketdataforecast.com/market-…ting-market-3662/

Mycoplasmas are more frequently found as contaminants in cell culture research laboratories. The contamination can either be carried inside by an individual or from the materials brought from outside the laboratory.

In order to prevent further contamination, mycoplasma testing is recommended for all cell culturists. There are many mycoplasma tests available in the market.

Mycoplasma infections cannot be allowed to grow in cell culture as they tend to bring changes in chromosomes and effect the cell growth.

Report: www.marketdataforecast.com/market-…62/request-sample

As the investments in research and development are increasing in the field of life sciences, the increase in demand for mycoplasma testing products is predicted in the forecast period. With the increase in healthcare expenditure all over the world, pharmaceutical and biotechnology industries are heavily investing in R&D activities.

Government Initiatives are funding research on drug discovery and development. All these factors are responsible for driving the growth of mycoplasma testing market.

However, strict government regulations and high costs of mycoplasma testing are the major restraining factors for the market.

Report: www.marketdataforecast.com/market-…/request-discount

Report: www.marketdataforecast.com/cart/my…ting-market-3662/

Market Segmentation                                              

Product                        

  • Kits & Reagent       
  • o PCR Assays
  • o Nucleic Acid Detection Kits
  • o Elimination Kits & Reagents
  • o Stains
  • o Standards & Controls
  • o Other Kits & Reagents
  • Instruments           
  • Services    
  • Y-o-Y Growth Analysis, By Product              
  • Market Attractiveness Analysis, By Product            
  • Market Share Analysis, By  Product             

Technique                   

  • PCR            
  • ELSA           
  • Direct Assays          
  • Indirect Assays      
  • Microbial culture techniques           
  • Enzymatic Methods            
  • DNA Staining          
  • Y-o-Y Growth Analysis, By Technique          
  • Market Attractiveness Analysis, By Technique      
  • Market Share Analysis, By Technique       

Application                 

  • Cell Line Testing    
  • Virus Testing          
  • End-Of-Production Cell Testing      
  • Other Applications               
  • Y-o-Y Growth Analysis, By Application         
  • Market Attractiveness Analysis, By Application      
  • Market Share Analysis, By Application       

End User                      

  • Pharmaceutical Companies              
  • Contract Research Organizations   
  • Academic Research Institutes         
  • Cell Banks
  • Y-o-Y Growth Analysis, By End User             
  • Market Attractiveness Analysis, By End User           
  • Market Share Analysis, By End User  

On the basis of geography, the market for mycoplasma testing is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. North America dominates the mycoplasma testing market and Europe is not far behind.

Asia-Pacific region is projected to have the fastest growth rate due to the huge opportunities available in countries like China, India and Japan. Increasing pharma and biotech companies and their investments in R&D and various government initiatives are expected to drive the market growth.

The key players in the mycoplasma testing market include Thermo Fisher Scientific Inc., Minerva Biolabs GmbH, Charles River Laboratories International, Inc., Gibraltar Laboratories, Sartorius AG, Lonza Group Ltd., Merck KGaA, Roche Diagnostics, SGS S.A., American Type Culture Collection, InvivoGen, PromoCell GmbH, Biological Industries Israel Beit Haemek Ltd., and WuXi AppTec.

 

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...